Leadoptik has entered a research partnership with Stanford Medicine, focusing on real-time optical imaging usage in lung ...

Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent.

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

MELBOURNE, Australia and PORTO ALEGRE, Brazil, /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

The Symbia Intevo Bold Eco SPECT-CT scanner enables medical experts to detect and trace cancer cells with unprecedented ...

A bill making its way through the Arizona legislature hopes to bring peace of mind by eliminating out-of-pocket expenses for ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining characteristics.

Lung cancer often goes undetected until it’s too late. But a new urine test developed by Cambridge scientists could change ...

Triple negative breast cancer accounts for 15% of cases but causes a disproportionate number of deaths. Learn about symptoms ...

Illuccix® is the first and only PSMA-PET1 prostate cancer imaging agent to receive full regulatory approval in Brazil. Illuccix®, after radiolabeling with 68Ga, is a radioactive diagnostic agent ...

An Arizona lawmaker has introduced a bill that could make getting medically necessary breast-imaging tests more affordable ...